This content is machine translated Urticaria & urticaria-like exanthema Case studies from pediatric dermatology The lifetime prevalence of urticaria is almost 20%. Second-generation antihistamines are also recommended as first-line therapy for pediatric patients. However, pediatric patients with itchy wheals are not always suffering from...…
View Post 7 min This content is machine translated Moderate to severe chronic hand eczema Delgocitinib cream – first topical pan-JAK inhibitor approved in Switzerland In the phase III DELTA 1 and 2 studies, delgocitinib cream showed a rapid onset of efficacy – at week 16, half of the patients achieved a 75% improvement in...…
View Post 4 min This content is machine translated Biologics for atopic dermatitis Th2 cytokines in focus: proven and new targets The range of antibody therapies for atopic dermatitis (AD) has expanded once again in Europe. In addition to dupilumab and tralokinumab, lebrikizumab is another biologic available in this country that...…
View Post 4 min This content is machine translated Oral JAK-i in atopic dermatitis Benefits and risks: What does the current data say? Although there have been no recent approvals of oral JAK inhibitors (JAK-i) for atopic dermatitis (AD), some interesting study findings have been published. These shed light on the safety of...…
View Post 4 min This content is machine translated Prurigo nodularis Retrospective analyses of large data sets from everyday practice Prurigo nodularis (PN) is a chronic inflammatory skin disease that manifests itself as extremely itchy hard nodules. Prof. Dr. med. Dr. rer nat. Enno Schmidt from the University Hospital Schleswig-Holstein...…
View Post 6 min This content is machine translated Chronic hand eczema Changing therapy landscape – a lot is happening Inflamed, itchy and sometimes painful skin lesions on the hands can significantly impair quality of life. If chronic hand eczema proves to be refractory to topical treatment, systemic therapy is...…
View Post 4 min This content is machine translated Basic therapy for atopic dermatitis “Emollients plus” with bacterial lysates There are various indications in the specialist literature that the gram-negative, non-pathogenic bacterium Vitreoscilla filiformis (V. filiformis) has a beneficial effect on atopic skin. New findings confirm earlier reports of...…
View Post 7 min This content is machine translated Treatment concepts for psoriasis Offering customized therapy It is scientifically proven that it is worth discussing the pros and cons of different treatment options with patients. In general, shared decision making has a favorable effect on clinically...…
View Post 8 min This content is machine translated Hidradenitis suppurativa/acne inversa Relieving suffering and inflammation – how can this be achieved? Quite a few patients affected by hidradenitis suppurativa/acne inversa suffer from disease manifestations long before targeted therapeutic measures are taken. There are various reasons for this. One approach to tackling...…
View Post 7 min This content is machine translated News on contact allergy and epicutaneous testing Current findings at a glance – Update 2025 Allergic contact dermatitis is based on type IV/late type sensitization. The selection of test allergens should be guided by the patient’s medical history. Nickel is still the most common trigger...… CME-Test
View Post 6 min This content is machine translated Atopic dermatitis: "Treat-to-target" Current secondary analyses expand the evidence base In the recent past, several secondary analyses have been published in which different treatment regimes for atopic dermatitis (AD) were compared and evaluated. In order to evaluate treatment progress using…
